Inside the Structural Reforms That Made IU Indianapolis a Translational Overachiever
How a resource-constrained university built a top-15 translation engine — and what other institutions can learn from it.
Fox Chase Cancer Center
39Institution Overview
#39In Institutes & Centers
#10In Research Capabilities
#46In Entrepreneurial Readiness
#34In Market Translation
Top in Research Capabilities
Philadelphia, PA
Fox Chase Cancer Center, based in Philadelphia, Pennsylvania, ranks 39th among the 60 biomedical institutes assessed by the Cure Innovation Index. Its research capabilities rank 10th in the category, reflecting a profile built around scientific investigation. Market translation and entrepreneurial readiness sit considerably lower, a pattern typical of institutes that emphasize discovery over commercialization. Faculty participate actively in clinical trials as principal investigators, grounding the center's work in patient-oriented research. As a cancer center, Fox Chase carries its comparative strength in the scientific foundations of the innovation pipeline.
Ranking Metrics
Research Capabilities
Fox Chase Cancer Center ranked above average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, Fox Chase Cancer Center fared best in Cutting Edge Science.
Learn MoreEntrepreneurial Readiness
Fox Chase Cancer Center ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, Fox Chase Cancer Center fared best in Ecosystem Support.
Learn MoreMarket Translation
Fox Chase Cancer Center ranked below average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, Fox Chase Cancer Center fared best in Industry Connections.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
New York State Has Built One of the Country’s Most Powerful Biomedical Ecosystems
With 27 institutions ranked among the country’s top biomedical innovators, New York’s research cluster spans the entire state, and outperforms nearly every other in the country.
Universities Face an Uncertain Future as Gap To Industry Keeps Growing
As NIH funding shrinks and industry pulls back from early-stage science, universities are rethinking how discoveries move from the lab to the market.
How Universities Became the Engine of the Biotech Industry
The Bayh-Dole Act turned federally funded research into a commercialization pipeline that built American biotech. Forty-five years later, that pipeline faces a new set of political and financial pressures that could reshape how it works.